Lantheus Appoints Julie Eastland as New Board Member Read more about Lantheus Appoints Julie Eastland as New Board Member
Julie Eastland Member of the Audit Committee Member of the Talent & Compensation Committee Julie Eastland Director
Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference Read more about Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
Lantheus to Present Additional Clinical Data from Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024 Read more about Lantheus to Present Additional Clinical Data from Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024
Lantheus Reports Second Quarter 2024 Financial Results Read more about Lantheus Reports Second Quarter 2024 Financial Results
Lantheus to Host Second Quarter 2024 Earnings Conference Call and Webcast on July 31, 2024, at 8:00 a.m. Eastern Time Read more about Lantheus to Host Second Quarter 2024 Earnings Conference Call and Webcast on July 31, 2024, at 8:00 a.m. Eastern Time
Lantheus Acquires NAV-4694, a Next-Generation ß Amyloid PET Imaging Agent for Alzheimer’s Disease Read more about Lantheus Acquires NAV-4694, a Next-Generation ß Amyloid PET Imaging Agent for Alzheimer’s Disease
Lantheus Welcomes CMS’ Proposed CY25 Rule for Improved Payment for Specialized Diagnostic Radiopharmaceuticals to Support Patient Access Read more about Lantheus Welcomes CMS’ Proposed CY25 Rule for Improved Payment for Specialized Diagnostic Radiopharmaceuticals to Support Patient Access
Lantheus Appoints Jamie Spaeth as Chief People Officer Read more about Lantheus Appoints Jamie Spaeth as Chief People Officer
